Homepage
PR Newswire
19-10-2011, 09:54 PM
Lately i read news saying the chinese medicines in china the price has been jacked up like crazy. It can gone up like double or triple. Obviously the businessmen there stock up the medicine and speculate the price.
But eu yan sang last quarter result don't seem like affected by this raw material price. The margin still maintain very well. I wonder how they manage to do that?
So far i only aware they only got a sole distribution right for american ginseng.
Recently this eu yan sang also start speculating in properties market, bought a industrial building in singapore, and shop houses in hong kong. The industrial building has no excuse, hong kong shop houses they claimed will use it for retails and head quarter. Anyway quite big sum of money.
But eu yan sang last quarter result don't seem like affected by this raw material price. The margin still maintain very well. I wonder how they manage to do that?
So far i only aware they only got a sole distribution right for american ginseng.
Recently this eu yan sang also start speculating in properties market, bought a industrial building in singapore, and shop houses in hong kong. The industrial building has no excuse, hong kong shop houses they claimed will use it for retails and head quarter. Anyway quite big sum of money.